CLOV vs UNMA · rev $1.37B vs P/E 4.6, rev $12.89B
Clover Health Investments Corp (CLOV) versus Unum Group 6.250% JR NT58 (UNMA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Unum Group 6.250% JR NT58 (UNMA) common stock listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported UNMA revenue for 2024-12-31 was $12.89B. Net income was $1.78B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. UNMA currently screens at market cap $5.35B and trailing P/E 4.6.
CLOV currently screens at market cap $1.55B. UNMA currently screens at market cap $5.35B and trailing P/E 4.6.
Not investment advice. Open the CLOV and UNMA stock pages for the full models.
Not investment advice.